Psilocybin in the Treatment of Cocaine Use Disorder
Hendricks Peter S., Lappan Sara N., Shelton Richard C., Lahti Adrienne C., Cropsey Karen L., Johnson Matthew W., Bradley Melissa, Simonsson Otto, Davis Lori L., Grossman Daniel H., Ortiz Cynthia E.
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (46)
- Psilocybin or Nicotine Patch for Smoking Cessation 2026-03-10 · Expand citations
- Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial. 2025-07-24 · Expand citations
- Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis. 2025-07-01 · Expand citations
- Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis. 2024-08-21 · Expand citations
- Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. 2024-06-01 · Expand citations
- Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. 2023-09-05 · Expand citations
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. 2022-10-01 · Expand citations
- Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations. 2022-08-15 · Expand citations
- Blinding and expectancy confounds in psychedelic randomized controlled trials. 2021-09-01 · Expand citations
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. 2020-10-01 · Expand citations
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- 10.1001/archpsyc.1973.01750360040005
- 10.1001/jama.2022.0395
- 10.1001/jamanetworkopen.2021.8049
- 10.1001/jamapsychiatry.2025.0085
- 10.1002/sim.1047
- 10.1007/s11606-019-05074-8
- 10.1007/s40732-017-0236-1
- 10.1016/j.drugalcdep.2010.11.004
- 10.1016/j.eclinm.2025.103149
- 10.1016/j.phrs.2024.107454
- 10.1016/s0005-7916(00)00012-4
- 10.1016/s2215-0366(23)00095-0
- 10.1037/0022-006x.59.4.526
- 10.1037/0022-006x.67.1.37
- 10.1037/0022-006x.68.3.515
- 10.1038/s41598-025-14895-z
- 10.1038/s44220-025-00417-3
- 10.1046/j.1360-0443.1995.9056072.x
- 10.1080/10543401003777995
- 10.1097/00001648-199001000-00010
- 10.1111/add.13327
- 10.1111/add.16200
- 10.1111/add.16529
- 10.1111/j.1360-0443.2004.00743.x
- 10.1111/j.1360-0443.2009.02879.x
- 10.1136/bmj-2024-081123
- 10.1136/bmj.316.7139.1236
- 10.1136/bmj.l6802
- 10.1176/appi.ajp.20250053
- 10.1177/0269881112439253
- 10.1186/s12991-015-0063-1
- 10.1371/journal.pone.0266142
- 10.2147/clep.s161508